Resolving Loss of Response to Ustekinumab in Crohn’s Disease: POWER Through or Switch Treatment?

Noviello D, Atreya R, Noor NM (2025)

Publication Type: Journal article

Publication year: 2025

Journal

Inflammatory Bowel Diseases Wiley

Book Volume: 31

Pages Range: 3237-3239

Journal Issue: 11

DOI: 10.1093/ibd/izaf179

Authors with CRIS profile

Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Involved external institutions

Università degli studi di Milano IT Italy (IT) Cambridge University Hospitals GB United Kingdom (GB)

How to cite

APA:

Noviello, D., Atreya, R., & Noor, N.M. (2025). Resolving Loss of Response to Ustekinumab in Crohn’s Disease: POWER Through or Switch Treatment? Inflammatory Bowel Diseases, 31(11), 3237-3239. https://doi.org/10.1093/ibd/izaf179

MLA:

Noviello, Daniele, Raja Atreya, and Nurulamin M. Noor. "Resolving Loss of Response to Ustekinumab in Crohn’s Disease: POWER Through or Switch Treatment?" Inflammatory Bowel Diseases 31.11 (2025): 3237-3239.

BibTeX: Download